Cart
sales@molnova.com
Diphyllin
CAS No. 22055-22-7
Diphyllin( —— )
Catalog No. M23994 CAS No. 22055-22-7
Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 88 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 351 | In Stock |
|
| 100MG | 529 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiphyllin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
-
DescriptionDiphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1|Vesicular stomatitis virus (VSV)|Vacuolar type H+-ATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22055-22-7
-
Formula Weight380.35
-
Molecular FormulaC21H16O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC1=C(C=C2C(=C1)C(=C3C(=C2O)COC3=O)C4=CC5=C(C=C4)OCO5)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anti-inflammatory activities of constituents isolated from Phyllanthus polyphyllus.J Ethnopharmacol. 2006 Jan 16;103(2):181-6.
molnova catalog
related products
-
YIR-819
YIR-819 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor.
-
BMS-986001
A thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV-2 isolates from treatment-naive individuals with EC50 of 30-81 nM.
-
Dolutegravir interme...
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
